We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
- Authors
Bertucci, François; Nonneville, Alexandre de; Finetti, Pascal; Mamessier, Emilie
- Abstract
During the last decade, chemotherapy plus dual anti-HER2 therapy (trastuzumab+pertuzumab) became the standard systemic therapy in HER2+ breast cancer. Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
- Subjects
HER2 positive breast cancer; METASTATIC breast cancer; GENE expression
- Publication
JNCI: Journal of the National Cancer Institute, 2023, Vol 115, Issue 6, p762
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djad060